We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danaher's Subsidiary Envista Prices IPO, to Trade as NVST
Read MoreHide Full Article
Danaher Corporation (DHR - Free Report) yesterday announced that its dental subsidiary, Envista Holdings Corporation, priced its initial public offering of common shares at $22.00 per share. Subject to the fulfillment of closing conditions, the offering will close on Sep 20, 2019.
It is worth mentioning here that Danaher announced about this plan for initial public offering of Envista in June this year. Yesterday, Danaher’s share price increased 1.19%, closing the trading session at $142.33.
Inside the Headlines
The share offering comprises approximately 26.8 million common shares of Envista. Gross proceeds (before deduction of any expenses related to underwriting and offering) of roughly $588.9 million are anticipated from this offering. Danaher will be awarded the consideration, after payment of related expenses as part payment for its dental assets.
Also, the underwriters have been provided with an option to purchase an additional 4 million shares within 30 days. The purchase price for the underwriters will be adjusted for commissions and underwriting discounts.
Envista shares, under the ticker symbol “NVST”, will trade on the NYSE. Danaher’s shares in Envista will be roughly 82.7% or 80.6%, provided overallotment option is completely used by the underwriters.
Brief on Envista
Envista consists Danaher Dental segment's three operating businesses — Nobel Biocare Systems, Ormco and KaVo Kerr. These businesses specialize in dental equipment, orthodontics, dental implants and consumables. Some notable brands are Nobel Biocare, Kerr, i-CAT, KaVo, Dexis, Pelton & Crane, Metrex, Ormco, Implant Direct, and Orascoptic.
Envista provides services to dentists (more than one million) in as many as 150 countries. It employs 12,000 people.
Zacks Rank, Earnings Estimates and Price Performance of Danaher
With a market capitalization of approximately $100.9 billion, Danaher currently carries a Zacks Rank #2 (Buy). In the past 60 days, the Zacks Consensus Estimate for its earnings has risen 0.2% to $4.79 for 2019 and 4.1% to $5.59 for 2020.
The company’s share price has increased 38.1% so far in 2019 compared with the industry’s growth of 19.9%.
Stocks to Consider
Three other top-ranked stocks in the industry are Federal Signal Corporation (FSS - Free Report) , Carlisle Companies Incorporated (CSL - Free Report) and United Technologies Corporation . While Federal Signal currently sports a Zacks Rank #1, Carlisle Companies and United Technologies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, earnings estimates for 2019 have improved for these companies. Further, earnings surprise in the last reported quarter was positive 19.57% for Federal Signal, 11.02% for Carlisle Companies and 7.84% for United Technologies.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Danaher's Subsidiary Envista Prices IPO, to Trade as NVST
Danaher Corporation (DHR - Free Report) yesterday announced that its dental subsidiary, Envista Holdings Corporation, priced its initial public offering of common shares at $22.00 per share. Subject to the fulfillment of closing conditions, the offering will close on Sep 20, 2019.
It is worth mentioning here that Danaher announced about this plan for initial public offering of Envista in June this year. Yesterday, Danaher’s share price increased 1.19%, closing the trading session at $142.33.
Inside the Headlines
The share offering comprises approximately 26.8 million common shares of Envista. Gross proceeds (before deduction of any expenses related to underwriting and offering) of roughly $588.9 million are anticipated from this offering. Danaher will be awarded the consideration, after payment of related expenses as part payment for its dental assets.
Also, the underwriters have been provided with an option to purchase an additional 4 million shares within 30 days. The purchase price for the underwriters will be adjusted for commissions and underwriting discounts.
Envista shares, under the ticker symbol “NVST”, will trade on the NYSE. Danaher’s shares in Envista will be roughly 82.7% or 80.6%, provided overallotment option is completely used by the underwriters.
Brief on Envista
Envista consists Danaher Dental segment's three operating businesses — Nobel Biocare Systems, Ormco and KaVo Kerr. These businesses specialize in dental equipment, orthodontics, dental implants and consumables. Some notable brands are Nobel Biocare, Kerr, i-CAT, KaVo, Dexis, Pelton & Crane, Metrex, Ormco, Implant Direct, and Orascoptic.
Envista provides services to dentists (more than one million) in as many as 150 countries. It employs 12,000 people.
Zacks Rank, Earnings Estimates and Price Performance of Danaher
With a market capitalization of approximately $100.9 billion, Danaher currently carries a Zacks Rank #2 (Buy). In the past 60 days, the Zacks Consensus Estimate for its earnings has risen 0.2% to $4.79 for 2019 and 4.1% to $5.59 for 2020.
Danaher Corporation Price and Consensus
Danaher Corporation price-consensus-chart | Danaher Corporation Quote
The company’s share price has increased 38.1% so far in 2019 compared with the industry’s growth of 19.9%.
Stocks to Consider
Three other top-ranked stocks in the industry are Federal Signal Corporation (FSS - Free Report) , Carlisle Companies Incorporated (CSL - Free Report) and United Technologies Corporation . While Federal Signal currently sports a Zacks Rank #1, Carlisle Companies and United Technologies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, earnings estimates for 2019 have improved for these companies. Further, earnings surprise in the last reported quarter was positive 19.57% for Federal Signal, 11.02% for Carlisle Companies and 7.84% for United Technologies.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.
See 7 breakthrough stocks now>>